CSPC PHARMA (01093.HK) -0.480 (-8.348%) Short selling $199.48M; Ratio 14.054% issued a profit warning, after which the stock opened 13.04% lower at $5 this morning (November 1). Before the market opened, 16.692 million shares were traded, involving $83.46 million. CSPC PHARMA’s profit warning estimated that the net profit for the nine months ending September will decrease by about 16% compared to the same period last year of RMB4.495 billion.UBS said that CSPC's 3Q results were way worse than expected, estimating that its 3Q net profit will slide about 51% YoY, which was about 50% and 52% radically lower than the market's and the broker's respectively. The 3Q revenue from finished drugs dropped about 19% YoY, which was also about 19% lower than market expectations. The broker expected investors to react negatively. The rating was Buy, with a target price $9.1.(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2024-11-01 16:25.)Related NewsM Stanley: CSPC PHARMA (01093.HK) 3Q Results Miss Strongly; Mkt Expected to Cut Forecasts for 2024 & Onward